We are monitoring the impact of COVID-19 & Recession alarm on Europe Cell Counting Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Cell Counting Market Research Report – Segmented By Product, Consumables, End User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Size, Share, Trends, Growth, Forecasts (2022 to 2027)

Published: January, 2022
ID: 5767
Pages: 145

Europe Cell Counting Market Size & Growth (2022 to 2027):

As Per the Report, the Europe Cell Counting Market Size was valued at USD 0.31 billion in 2022 and is expected to grow at a CAGR of 6.8%, to reach USD 0.43 billion by 2027 during the forecast period 2022 to 2027.

The increased incidence of target diseases such as HIV, measles, and diphtheria and chronic diseases such as cancer and other blood disorders is primarily driving market expansion. According to the World Health Organization (WHO), almost 7.9 million people in Europe were infected with HIV in 2018. The majority of this prevalence has been discovered in poor and middle-income nations.

Cell counters are becoming more widely used in various applications, including research, diagnostics, and industry. Cell counting instruments are increasingly being used in multiple fields of study, including cancer biology, immunology, and neuroscience, and the market is expected to grow exponentially. In addition, as the number of chronic diseases rises, the demand for tools increases.

Furthermore, the government's increasing financing for cell counting research boosts industry growth. The market expansion is supplemented by inspiring attitudes toward stem cell research, increased funding, and widespread awareness of stem cells.

The rising frequency of AIDS and cancer is one of the primary factors driving the worldwide cell counting industry. Cell counting is used to ensure intra-tumor heterogeneity, which is an essential step in tracking cancer growth in the patient's body.

Due to the high costs of the apparatus, equipment, and procedures, many people are hesitant to spend money on cell counting methods for medical or research purposes 

Furthermore, most countries have underdeveloped healthcare infrastructure and antiquated technology, which severely hinders the growth of cell counting. Moreover, the cell counting market's progress is hampered by a scarcity of competent personnel.

The expansion of the market in Europe is being hampered by a scarcity of experienced professionals combined with insufficient research infrastructure, particularly in emerging markets.

This research report on the Europe Cell Counting Market has been segmented and sub-segmented into the following categories.

By Product:

  • Instruments
  • Cell Counters
  • Hematology Analysers
  • Spectrophotometer
  • Flow Cytometer
  • Hemocytometer
  • Others

By Consumables:

  • Microplates
  • Reagent
  • Assay Kits

By End User:

  • Pharmaceutical & Biotechnology Industries
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Europe is expected to have the second-highest share of the global cell counting market throughout the projected period. The significant portion is a larger patient pool and an aging population.

The United Kingdom Cell Counting Market and Germany Cell Counting Market have the largest market share in Europe, owing to an increasing number of chronic diseases and a growing number of research and development programs in the country.

Growing demand for high-tech instruments in research and diagnostic applications, high incidence of target conditions, increased focus on stem cell, biomedical, and cancer research, rising prevalence of chronic diseases, and growing demand for early diagnosis and effective treatment of diseases are all contributing to this segment's large share.

The rising number of stem cell, genomics, and proteomic research activities, the vast genome pool, the growing trend for research infrastructure modernization, low development costs, less complicated regulations, and increasing investments by pharmaceutical and biotechnology companies contribute to this growth.

The European cell counting market is expected to grow in the coming years due to the rising prevalence of chronic diseases and blood-related disorders, technological advancements in this segment, and the expanding biopharmaceutical and biotechnology industries.


Major Companies Operating the Europe Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.,

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemiology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Instruments                           

                                       Cell Counters      

                                                       Automated Cell Counters

                                                       Hemocytometers and Manual Cell Counters

                                       Hematology Analysers   


                                                       Single-Mode Readers

                                                       Multi-Mode Readers

                                       Flow Cytometer



                                5.1.3 Consumables                         



                                       Assay Kits             



                                5.1.4 Y-o-Y Growth Analysis, By Product                               

                                5.1.5 Market Attractiveness Analysis, By Product                             

                                5.1.6 Market Share Analysis, By Product                               

                5.2 End-user                                      

                                5.2.1 Introduction                           

                                5.2.2 Pharmaceutical & Biotechnology Industries                              

                                5.2.3 Hospitals & Diagnostic Laboratories                              

                                5.2.4 Research & Academic Institutes                    

                                5.2.5 Others                      

                                5.2.6 Y-o-Y Growth Analysis, By End-user                             

                                5.2.7 Market Attractiveness Analysis, By End-user                           

                                5.2.8 Market Share Analysis, By End-user                             

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                       By Geographical Area     

                                       By Product           

                                       By End-user        

                                6.1.4  Market Attractiveness Analysis                     

                                       By Geographical Area     

                                       By Product           

                                       By End-user        

                                6.1.5  Market Share Analysis                      

                                       By Geographical Area     

                                       By Product           

                                       By End-user        

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France     

                6.7 Rest of Europe                                     

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Thermo Fisher Scientific, Inc.,                                             

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Danaher Corporation                                             

                8.3 Agilent Technologies                                              

                8.4 Bio-Rad Laboratories                                              

                8.5 Merck Millipore, Inc.,                                             

                8.6 GE Healthcare                                           

                8.7 Becton, Dickinson and Company                                       

                8.8 PerkinElmer, Inc.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, Collaborations, and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         


                a) List of Tables                                

                b) List of Figures                                              

  1. Europe Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  2. Europe Instruments Market By Region, From 2022 to 2027 ( USD Billion )
  3. Europe Consumables Market By Region, From 2022 to 2027 ( USD Billion )
  4. Europe Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )
  5. Europe Pharmaceutical & Biotechnology Industries Market By Region, From 2022 to 2027 ( USD Billion )
  6. Europe Hospitals & Diagnostic Laboratories Market By Region, From 2022 to 2027 ( USD Billion )
  7. Europe Research & Academic Institutes Market By Region, From 2022 to 2027 ( USD Billion )
  8. Europe Others Market By Region, From 2022 to 2027 ( USD Billion )
  9. U.K. Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  10. U.K. Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )
  11. Germany Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  12. Germany Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )
  13. France Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  14. France Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )
  15. Italy Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  16. Italy Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )
  17. Spain Cell Counting  Market By Product, From 2022 to 2027 ( USD Billion )
  18. Spain Cell Counting  Market By End User , From 2022 to 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample